BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Endothelial cell
,
DNA fingerprint
,
Quercetin
,
rs4950928
,
LEP
,
Apoptosis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NK1.1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Listeriosis
Vesicular stomatitis Indiana virus disease
Meningitis
Viral infections of the central nervous system
Injury of lung
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
vaccinia-CEA vaccine
ovalbumin-alum
Carbon Black
Trinitrobenzenesulfonic Acid
4-hydroxyestradiol-17 beta
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
BP1
HSA251708
HNRNPA0
PSEN1
APP
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Thymic invariant natural killer T cells (CD24- CD44+/- NK1.1-) with Id3 knockout
Natural killer and natural killer T cells from Eomes reporter mice
Natural killer T cells from DOCK8 deficient or wildtype mice
Dendritic cell populations CCL17-positive (lymph nodes) or CCL17-negative (spleen)
Thymocytes double negative 3 (DN3) conditionally overexpressing miR-185
Explore Curated Studies Results
Literature
Most Relevant Literature
LLT1-CD161 Interaction in Cancer: Promises and Challenges.
Poor clinical outcomes and immunoevasive contexture in CD161+CD8+ T cells barren human pancreatic ca…
Targeting of the CD161 inhibitory receptor enhances T-cell-mediated immunity against hematological m…
Immune checkpoint CD161/LLT1-associated immunological landscape and diagnostic value in oral squamou…
The proportion of CD161 on CD56+ NK cells in peripheral circulation associates with clinical feature…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prur…
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With […
A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bull…
Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressiv…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ